261G000485 - RITUXIMAB 500 MG/50 ML INJ BIOSS 50 ML IV TRUXIMA
TED · 306226-2026Award noticeawardedNo deadline given
Value
Estimated€254,787 · 254,787 EUR
Awarded€254,787 · 254,787 EUR
WinnerCELLTRION PORTUGAL UNIPESSOAL LDA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 22 | — | 2026-08-04 |
| GILEAD SCIENCES, LDA | 18 | — | 2026-07-28 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 15 | €1,569,649 | 2026-08-04 |
| NOVARTIS FARMA - PROD.FARM SA | 11 | — | 2026-08-04 |
| JANSSEN-CILAG FARMACEUTICA LDA | 9 | €371,730 | 2026-08-04 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
RITUXIMAB 500 MG/50 ML INJ BIOSS 50 ML IV TRUXIMA
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-21 | 2023/0491 - TRASTUZUMAB [600 MG/ 5 ML SOL INJ SC FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-05-05 | 261G000469 - INFLIximab 100 MG INJ BIOSSIMILAR (ZESSLY) | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-07-21 | 261G000782 - MARALIXIBAT 9,5 MG/ ML FR 30 ML SOL ORAL | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-05-05 | 261G000236 - NATALIzumab INJ 20MG/ML AMP 15 ML | Unidade Local de Saúde Santa Maria, E.P.E. PT | 91% |
| 2026-07-21 | 261G000791 - BINIMEtinib 45 MG COMP | Unidade Local de Saúde Santa Maria, E.P.E. PT | 91% |
| 2026-05-05 | 261G000431 - USTECINUMAB SOL INJ BIOSSIMILAR (PYZCHIVA) | Unidade Local de Saúde Santa Maria, E.P.E. PT | 91% |